Paramesu Biotech IPO

About Paramesu Biotech

Paramesu Biotech (PBL), established in 2011 and headquartered in Devarapalli, Andhra Pradesh, is a prominent manufacturer of maize-based specialty products in India. The company offers a diverse portfolio, including native and modified maize starches, liquid glucose, maltodextrin powder, and co-products like corn gluten meal, fiber, and corn steep liquor. Serving industries such as food, pharmaceuticals, textiles, and paper, PBL has a significant domestic presence across 14 states and 4 union territories, and exports to over 10 countries in Southeast Asia and the Middle East. Recognized as a Two-Star Export House by the Indian Ministry of Commerce, the company is expanding its capacity with a new 1,200 TPD plant in Madhya Pradesh.

Financials of Paramesu Biotech

*All figures are in ₹ Crores.

Issue size

Utilisation of proceeds

Strengths

• A diverse product portfolio serving multiple industries enhances market reach.
• Strong domestic and international presence with exports to over 10 countries.
• Recognized as a Two-Star Export House, indicating robust export capabilities.
• The high capacity utilization rate of 93% in FY2024 reflects operational efficiency. 
• Ongoing expansion with a new 1,200 TPD plant to meet growing demand

Risks 

• Exposure to agricultural commodity price volatility can impact profitability. 
• High competition in a fragmented industry may pressure margins.
• Significant capital expenditure for expansion could strain financial resources.
• Dependence on weather conditions affects raw material availability and costs.
• Regulatory changes in the agro-processing sector may pose compliance challenges